| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/05/1998 | US5747489 Arylalkyl-thiadiazinones |
| 05/05/1998 | US5747488 2-aryl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-E! 1, 4!diazepines and their use in the treatment of HIV infection |
| 05/05/1998 | US5747318 Mitogen activated c-Fos regulating kinase, FRK |
| 05/05/1998 | US5747315 DNA encoding aspartyl tRNA synthetase from Streptococcus pneumoniae |
| 05/05/1998 | US5747314 Nucleotides and genetic vectors |
| 05/05/1998 | US5747313 DNA encoding histidyl tRNA synthetase from Streptococcus pneumoniae |
| 05/05/1998 | US5747303 Intermediates of peptide antagonists of neurotensin |
| 05/05/1998 | US5747286 Polynucleotides encoding a transcriptional response regulator of Streptococcus pneumoniae |
| 05/05/1998 | US5747269 Determination of peptide motifs on MHC molecules |
| 05/05/1998 | US5747050 Peat-derived bioactive products, pharmaceutical and cosmetic compositions containing said products and processes for producing said products and compositions |
| 05/05/1998 | US5747047 Purified mite allergen |
| 05/05/1998 | US5747040 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 05/05/1998 | US5747037 Monoclonal antibodies bound to epitopes secreted by hybridomas |
| 05/05/1998 | US5747034 Methods and materials for the induction of T cell anergy |
| 05/05/1998 | US5746996 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| 04/30/1998 | WO1998017810A2 Multi-functional chimeric hematopoietic receptor agonists |
| 04/30/1998 | WO1998017795A1 Nucleic acid encoding ds-cam proteins and products related thereto |
| 04/30/1998 | WO1998017794A1 Human eosinophil-derived basic protein |
| 04/30/1998 | WO1998017680A1 Peptide analogues containing a 7-membered lactam ring |
| 04/30/1998 | WO1998017313A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases |
| 04/30/1998 | WO1998017302A1 Total synthesis of the amino hip analogue of didemnin a |
| 04/30/1998 | WO1998017300A1 Mucin-mediated immunomodulation |
| 04/30/1998 | WO1998017295A1 Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions, and method of cosmetic treatment using a ginkgo biloba extract |
| 04/30/1998 | WO1998017292A1 Pharmaceutical compositions containing parthenium integrifolium or parts thereof or an extract or component thereof, the use of such plant material for preparing certain medicines, and a method of preparing an extract of parthenium integrifolium |
| 04/30/1998 | WO1998017279A1 Immune response modifier compounds for treatment of th2 mediated and related diseases |
| 04/30/1998 | WO1998017275A1 Semi-synthetic studies toward didemnin analogues |
| 04/30/1998 | WO1998004694A3 Secreted proteins and polynucleotides encoding them |
| 04/30/1998 | DE19644422A1 Use of terpene(s) as immunosuppressant, anti-retroviral or anti-leukaemia |
| 04/30/1998 | CA2751712A1 Immunotherapy and improved vaccines |
| 04/30/1998 | CA2269881A1 Semi-synthetic studies toward didemnin analogues |
| 04/30/1998 | CA2269878A1 Total synthesis of the amino hip analogue of didemnin a |
| 04/30/1998 | CA2269614A1 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases |
| 04/30/1998 | CA2269349A1 Mucin-mediated immunomodulation |
| 04/30/1998 | CA2268742A1 Multi-functional chimeric hematopoietic receptor agonists |
| 04/30/1998 | CA2268016A1 Human eosinophil-derived basic protein |
| 04/30/1998 | CA2240997A1 Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions, and method of cosmetic treatment using a ginkgo biloba extract |
| 04/29/1998 | EP0838453A1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/29/1998 | EP0838213A1 Use of Krill Enzymes for the Treatment of Dental Plaque |
| 04/29/1998 | EP0837928A1 Recombinant poxvirus - cytomegalovirus compositions and uses |
| 04/29/1998 | EP0837927A1 Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions |
| 04/29/1998 | EP0837926A2 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 04/29/1998 | EP0837881A2 CONJUGATES OF alpha-MSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG |
| 04/29/1998 | EP0837860A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO 3,4-c]-1,2,4-TRIAZOLO 4,3-$g(a)]PYRIDINES |
| 04/29/1998 | EP0837696A1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 04/29/1998 | EP0837694A1 Leptospira membrane proteins |
| 04/29/1998 | EP0837691A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease |
| 04/29/1998 | EP0837678A1 N,n-dimethyl-8,8-dipropyl-2-azaspiro 4,5]decane-2-propanamine dimaleate |
| 04/29/1998 | EP0837672A1 Preparations and methods for the treatment of t cell mediated diseases |
| 04/29/1998 | EP0722448A4 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
| 04/29/1998 | EP0722340B1 Immunological tolerance-inducing agent |
| 04/29/1998 | EP0537191B1 Treatment of organ transplantation rejection |
| 04/29/1998 | EP0465529B1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 04/29/1998 | CN1180374A Method of preparing undifferentiated cell |
| 04/29/1998 | CN1180359A Ascomycins |
| 04/29/1998 | CN1180352A Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 04/29/1998 | CN1180065A Antianaphylaxis, anti-asthma and anti-inflammatory new medicine |
| 04/28/1998 | US5744580 Fusion protein |
| 04/28/1998 | US5744480 Antiinflammatory agents, nervous system disorders |
| 04/28/1998 | US5744347 Excising; detaching from membrane; collecting cells displaying a particular phenotype capable of giving rise to blood cells |
| 04/28/1998 | US5744338 DNA encoding seryl tRNA synthetase from Staphylococcus aureus |
| 04/28/1998 | US5744316 Used to identify individuals diagnosed with conditions characterized by cellular abnormalities |
| 04/28/1998 | US5744143 Viral vaccines |
| 04/28/1998 | CA2076650C Roquinimex for treating hiv infections |
| 04/28/1998 | CA2030108C Process for the preparation of genetic vectors for the expression of nerve growth factor in eukaryotic cells |
| 04/23/1998 | WO1998016553A1 Bordetella strain expressing the fha hybrid, liposomes and vaccines |
| 04/23/1998 | WO1998016552A1 Helicobacter pylori live vaccine |
| 04/23/1998 | WO1998016520A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016503A2 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016247A1 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 04/23/1998 | WO1998016238A2 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 04/23/1998 | WO1998016205A2 Stable glassy state powder formulations |
| 04/23/1998 | WO1998016186A2 Monocyclic l-nucleosides, analogs and uses thereof |
| 04/23/1998 | WO1998016184A2 Purine l-nucleosides, analogs and uses thereof |
| 04/23/1998 | WO1998010076A3 Phospholipase d and dna sequences |
| 04/23/1998 | WO1998009992A3 Htm4, methods of treatment and assays, agonists and antagonists |
| 04/23/1998 | CA2268897A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268894A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268033A1 Helicobacter pylori live vaccine |
| 04/23/1998 | CA2267279A1 Monocyclic l-nucleosides, analogs and uses thereof |
| 04/23/1998 | CA2266889A1 Purine l-nucleosides, analogs and uses thereof |
| 04/22/1998 | EP0837137A2 Novel topoisomerase III |
| 04/22/1998 | EP0837136A2 Novel topoisomerase I |
| 04/22/1998 | EP0837133A2 DNA strand resolution proteins of the resolvase family |
| 04/22/1998 | EP0837130A2 M protein analogue from Streptococcus pneumoniae |
| 04/22/1998 | EP0837129A1 Epimorphin antagonist and process for producing the same |
| 04/22/1998 | EP0836850A2 Method of preventing allograft rejection |
| 04/22/1998 | EP0836621A1 Novel human g-protein coupled receptor |
| 04/22/1998 | EP0836616A1 Macrolides |
| 04/22/1998 | EP0836592A1 Azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases |
| 04/22/1998 | EP0741686B1 New leukotriene b4 derivatives, methods of preparing them and their use as drugs |
| 04/22/1998 | EP0708755B1 Novel vitamin d analogues |
| 04/22/1998 | EP0708644A4 TREATMENT OF -i(CRYPTOCOCCUS NEOFORMANS) INFECTION |
| 04/22/1998 | EP0536275B1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 04/22/1998 | CN1179774A Arginine analogues having nitric oxide synthase inhibitor activity |
| 04/22/1998 | CN1179311A Chinese patent medicine for treating various autoimmune diseases and preparing process thereof |
| 04/22/1998 | CN1038131C Pyrrolopyrimidines and its preparing intermediate and medicinal composition containing same and use |
| 04/21/1998 | US5741815 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 04/21/1998 | US5741810 Prostaglandins for ocular hypotension for treatment of glaucoma |
| 04/21/1998 | US5741809 Compounds and methods for the treatment of cardiovascular inflammatory and immune disorders |
| 04/21/1998 | US5741790 Tachykinin antagonist and intermediates for nervous system disorders, antiinflammatory agents, antiarthritic agents, antidepressants and gastrointestinal disorders |